HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway. [electronic resource]
- Atherosclerosis 04 2017
- 83-96 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
1879-1484
10.1016/j.atherosclerosis.2016.09.003 doi
Activating Transcription Factor 3--metabolism Anti-Inflammatory Agents--pharmacology Cells, Cultured Ceramides--metabolism Dose-Response Relationship, Drug Endothelial Cells--drug effects Humans Immunity, Innate--drug effects Inflammation Mediators--metabolism Lipopolysaccharides--pharmacology Lipoproteins, HDL--pharmacology Mitogen-Activated Protein Kinases--metabolism Palmitic Acid--metabolism Phosphatidylinositol 3-Kinase--metabolism Protein Kinase C--metabolism Proto-Oncogene Proteins c-akt--metabolism Signal Transduction--drug effects Time Factors